Identifying Substance Use Consequences
Development and Validation of a Measure of Substance-Related Consequences: A Novel Clinical Outcome Assessment for Substance Use Disorder Trials
2 other identifiers
observational
50
1 country
1
Brief Summary
The goal of this study is to develop a new tool for measuring substance use disorder treatment outcome. We will start by interviewing people and gathering advisory groups to develop the items for this new tool.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 10, 2026
CompletedFirst Submitted
Initial submission to the registry
March 25, 2026
CompletedFirst Posted
Study publicly available on registry
March 31, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2027
March 31, 2026
March 1, 2026
1.4 years
March 25, 2026
March 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Extracted Themes
thematic analysis of qualitative interviews to extract common themes
same-day, single session
Thematic analysis
qualitative assessment using formal thematic analysis to extract common themes from qualitative interviews
single-session, same day
Study Arms (1)
substance use disorder
people with lived experience with substance use disorder, a family member of someone with a substance use disorder or clinical provider treating substance use disorders
Interventions
this is not an intervention study
Eligibility Criteria
people with substance use disorders, their family members, and substance use disorder clinical providers
You may qualify if:
- (1) ability to read and provide informed consent in English, and at least one of the following 2a) currently providing direct care to patients with substance use disorders, 2b) current or past treatment for an substance use disorder, or 2c) self-report of a close friend or family member who currently or previously received treatment for a substance use disorder.
You may not qualify if:
- \) major psychiatric or medical condition that would interfere with participation (e.g., acute psychosis, severe withdrawal); 2) current intoxication (positive breath alcohol test or behavioral evidence of other substance intoxication).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mclean Hospitallead
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (1)
McLean Hospital
Belmont, Massachusetts, 02478, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 25, 2026
First Posted
March 31, 2026
Study Start
February 10, 2026
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
July 31, 2027
Last Updated
March 31, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
Only extracted themes will be shared as part of data sharing requirements from the study sponsor.